Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
about
Biosafe nanoscale pharmaceutical adjuvant materialsDrug Carriers: Not an Innocent Delivery ManSupramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapyAssessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data.Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicityChitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment.Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approachPolymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.Drug targeting and tumor heterogeneity.How nanotechnology can enhance docetaxel therapy.Noninvasive optical imaging of nanomedicine biodistribution.Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokineticsNanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelTargeted hyperthermia using metal nanoparticles.Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells.Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.Drug delivery to the CNS and polymeric nanoparticulate carriers.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Docetaxel nanotechnology in anticancer therapy.Current development in nanoformulations of docetaxel.Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications.Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.Recent Advances and Future Prospects of Aggregation-induced Emission Carbohydrate Polymers.Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells.Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence.Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
P2860
Q26829798-54EE7ED5-88D3-47D9-BAF6-32FB0C73DC76Q28082414-2B49C79E-390A-4F66-997F-7CF7FC4C336AQ31044568-66FC656F-678C-47E0-BA9D-1A8745359396Q34159161-276A1622-9D28-4EA4-AF07-2BAE59D562C2Q34331895-525B9B12-7934-477A-ACBF-3E2C11A6F428Q34394402-01F8844D-E24C-4F64-B4DB-8EBF55009DF5Q34481521-D1ED343D-A1B9-4DBC-A228-0739B9BA57F5Q34733812-B33A4AAD-5343-44A7-A448-A18967E32606Q34780593-C89252F2-5838-46B5-AA0D-3B880A2A8DD6Q35556934-83679382-2F92-4932-842E-FD38D757FFACQ35868357-8C5BAAD8-9E57-483D-820E-2F11DAB29022Q36316919-AB948D99-300D-44DE-A39A-E440A9F3E8C4Q36777292-9458BE74-DB16-487D-A3CA-2C0786DEC86FQ37064520-DD35AA26-2863-4F5C-9988-612892EEB560Q37091683-B0922563-538F-4065-94F1-8ECCF5057308Q37095731-82A82DED-852B-446C-A52A-B4A07DF47D9CQ37248684-4F49555B-63EF-4E61-AB91-AED78B89EC8CQ37262298-299C4A57-D520-4C27-9098-ECD1D5EC72BAQ37330824-DCCCC61C-DF91-4587-BA2B-D3456CE3A8DEQ37631871-4B3C0945-8508-428E-BEFE-9EBB36AEE3EBQ37642547-7DD903F7-9AA3-4BC6-A31C-B2AF6B70ACFAQ37729225-AD230DC7-5590-4F51-AFCC-392146E3E053Q37788222-3E52AFB5-B692-4F5D-A7CC-A557F74AF2ECQ37856301-3F97A03C-D4B5-48B4-876D-966761C26A41Q37938830-916C47F7-296C-4C9F-8D09-EE03F9B36612Q38003964-3FF5E3E4-BDF7-4ABB-859D-B6B5F3DB5564Q38019047-36A45ABE-95FE-46E1-93EE-0867CE07F317Q38039086-DDCC7DAC-D399-4EBF-A6A3-7A32A9C95D0AQ38126555-155A2875-D52F-4C54-AD57-FA1FF7A088B6Q38199152-C75524C3-541D-4279-9F0B-AD674AD61C05Q38260732-A9EB2F7A-3900-49BE-ADAD-D3761DB796B2Q38504324-5EF9DD0F-C642-47E9-A60C-91C04A88D4C7Q38721673-909BCD0F-CCF8-4EE1-9524-97BC7D34EEB7Q38749860-F0B16DE9-E13E-4D4F-A513-9E8F5E106517Q38769824-40D8EBBD-D929-4200-B204-380B05D33F9AQ38775340-DA6A1203-0704-4E29-9A8C-525CB11E7368Q38810269-59964A96-AEEE-438C-80EC-A030DA3BC420Q38853328-A0AC4DD4-7ACE-44C0-82BB-01D4FDEC6EE0Q38974572-B22887B9-08DB-4293-93D7-5F3A6E9EE291Q39122521-B6362C6F-6456-409C-8DC2-7BA5170408A4
P2860
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@en
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@nl
type
label
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@en
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@nl
prefLabel
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@en
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@nl
P2093
P1476
Tumor targetability and antitu ...... glycol chitosan nanoparticles.
@en
P2093
Ho-Young Hwang
In-San Kim
Yong-Hee Kim
P356
10.1016/J.JCONREL.2008.02.003
P407
P577
2008-02-20T00:00:00Z